51 more jobs expected from CTD Holdings’s new biotech headquarters in Jupiter
WEST PALM BEACH, FLA – CTD Holdings, a biotechnology company that develops cyclodextrin-based products for the treatment of disease, announced today it’s establishing its corporate headquarters in Jupiter. The move will add 51 new jobs and a $2.75 million investment to the Palm Beach County region.
The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and the EU, is used to treat Niemann-Pick Type C, a rare and fatal genetic disease.
Kelly Smallridge, President and CEO of the Business Development Board of Palm Beach County said, “CTD Holdings is an example of the many sophisticated biotechnology companies that are locating to and expanding in Palm Beach County. To further strengthen and grow Palm Beach County’s life science ecosystem and proactively attract more businesses like CTD Holdings, the BDB created a Life Science Advisory Council. The Council is a collaborative effort between the BDB, educators, research institutes, hospitals, government, and medical device, pharmaceutical/ nutraceutical, venture capital, and technology transfer companies.”
“CTD Holdings is pleased to be locating to Jupiter in order to build out our company and our drug development programs,” said N. Scott Fine, CTD Chairman & CEO. “We are grateful to Governor Scott and his team, as well to our local colleagues and officials in Palm Beach County and the City of Jupiter for all their support as we make this important move.”
“CTD’s presence in Jupiter not only provides high-quality bioscience jobs, it also helps to further solidify Jupiter’s position as a biotechnology hub where important scientific advances are realized,” said Jupiter Mayor Todd Wodraska.
Read More here. Courtesy photo